Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,815 public trials 832 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

NCT05568979

Conditions
Infections, Influenza (Healthy Volunteers), Influenza, Human, +5 more
Locations
  • Investigational Site Number : 2-2-002 Helsinki, Finland
  • Investigational Site Number : 2-2-005 Jyväskylä, Finland
  • Investigational Site Number : 2-2-004 Kuopio, Finland
  • Investigational Site Number : 2-2-006 Rauma, Finland
View all 15 locations
View Trial Details
Completed

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

NCT04669691

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • 23302- Al Mare Perearstikeskus OÜ Tallinn, Harju, Estonia
  • 23301- Clinical Research Center Tartu, Estonia
  • 60805 - De La Salle Medical and Health Sciences Institute Dasmariñas, Manila, Philippines
  • 60804 - University of Perpetual Help Dalta Medical Center Las Piñas, Manila, Philippines
View Trial Details
Completed

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

NCT04646044

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Disease 2019, +18 more
Locations
  • A G A Clinical Trials - HyperCore - PPDS Hialeah, Florida, United States
  • New Generation Medical Research Hialeah, Florida, United States
  • Clinical Site Partners - Winter Park - HyperCore -PPDS Winter Park, Florida, United States
  • SMS Clinical Research, LLC Mesquite, Texas, United States
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

NCT05052697

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • North Alabama Research Center Athens, Alabama, United States
  • The Heart Center Athens, Alabama, United States
  • Arizona Heart Rhythm Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
View all 100 locations
View Trial Details
Completed

Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)

NCT05435027

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, COVID-19, +23 more
Locations
  • Newtown Clinical Research Centre Johannesburg, South Africa
  • WITS RHI Shandukani Research Centre Johannesburg, South Africa
  • Wits Vaccines & Infections Diseases Analytics (VIDA) Research Unit Johannesburg, South Africa
  • Setshaba Research Center Pretoria, South Africa
View Trial Details

Related conditions